Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia

NCT03860597 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.

NCT NCT03860597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03860597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia
Lead sponsor
University of California, San Diego
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2018
Completion date
March 31, 2021
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy, schizo affective disorder, schizoaffective disorder, schizophrenia